Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 20, 2017

View Archived Issues

Denovo Biopharma will evaluate enzastaurin in biomarker-guided phase III study

Lucinactant shows favorable activity against bird flu in preclinical proof-of-concept study

Sobi adds rFIXFc-XTEN to its collaboration agreement with Bioverativ

Phase III SUNBEAM trial of oral ozanimod in patients with RMS meets primary endpoint

HSR clearance for collaboration and license agreement between Momenta and CSL

Oxidized form of membrane-bound vimentin as novel noninvasive biomarker of senescence

Small molecule UPC-K-005 acts through a novel inhibitory allosteric site in p38alpha

OlympiAD study supports utility of Myriad's BRACAnalysis CDx test in breast cancer

Takeda completes acquisition of Ariad Pharmaceuticals

Clinical data show malaria vaccine candidate PfSPZ-CVac is safe and efficacious

METIV-HCC phase III trial of tivantinib in HCC fails to meet primary endpoint

Toyama Chemical, Fujifilm identify novel C-X-C motif chemokine 10 inhibitors

Progenra describes new USP7/USP47 inhibitors

Immune Pharmaceuticals plans pivotal study of Ceplene in AML to support U.S. approval

Shire reflects on progress during fourth quarter of 2016

Grants supports work at University of Florida on improved Zika diagnostics

Kalytera Therapeutics completes acquisition of Talent Biotechs

Faron initiates phase II trial of Traumakine in patients with RAAA

EGFR(V)-EDV-dox nanocells carrying doxorubicin receives FDA orphan drug designation

Modus Therapeutics completes financing to support phase II trial of sevuparin

Autologous adipose-derived stromal vascular fraction cells studied in patients with Crohn's fistulas

EMA accepts Mereo's BPS-804 for Adaptive Pathways program

MIR17 family found to be a promising target for treating polycystic kidney disease

AstraZeneca licenses Zoladex commercial rights to TerSera in U.S. and Canada

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...